MRI of the cochlea with superparamagnetic iron oxide nanoparticles compared to gadolinium chelate contrast agents in a rat model

European Journal of Nanomedicine

Volumn 2, Issue 2, 2009, Pages 29-36

  Poe, Dennis ^a   Zou, Jing ^a   Zhang, Weikai ^a   Qin, Jian ^b   Ramadan, Usama Abo ^c   Fornara, Andrea ^b   Muhammed, Mamoun ^b   Pyykkö, Ilmari ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Animal; Contrast agent; Fluids; Inner ear; MRI; Nanotechnology; Neuron

Indexed keywords

CARRIER VEHICLES; CONTRAST AGENT; DELIVERY VEHICLE; FAST LOW ANGLE SHOTS; HIGH RESOLUTION; HIGH RESOLUTION IMAGE; HIGH-TEMPERATURE DECOMPOSITION; IN-VIVO; INNER EAR; INTRAVENOUS INJECTIONS; LOSS-OF-SIGNAL; MEMBRANE PERMEATION; MRI; MRI SCAN; MRI SCANNERS; PHANTOM TESTS; PLURONICS; PRE-TREATMENT; RAPID ACQUISITION; RAT MODEL; SIGNAL INTENSITIES; STRONG ENHANCEMENT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; T2 RELAXATION; T2 RELAXATION TIME; T2 WEIGHTED; THERAPEUTIC AGENTS;

AGGLOMERATION; ANIMALS; CATHETERS; CURRICULA; DISEASES; FLUIDS; GADOLINIUM; IRON OXIDES; NANOPARTICLES; NANOTECHNOLOGY; RELAXATION PROCESSES; SCANNING; SUPERPARAMAGNETISM; TISSUE;

MAGNETIC RESONANCE IMAGING;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; GADOLINIUM CHELATE; GADOTERATE MEGLUMINE; MEDETOMIDINE; POLOXAMER; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE PLURONIC F 127 CONJUGATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCHLEA; COCHLEA FENESTRA; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; ENDOLYMPH; IMAGE ANALYSIS; IN VIVO STUDY; INNER EAR; INTRACOCHLEAR DRUG ADMINISTRATION; MALE; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERILYMPH; PHANTOM; RAT; SCALA VESTIBULI;

EID: 79551699165     PISSN: 16625986     EISSN: 1662596X     Source Type: Journal    
DOI: 10.3884/0002.2.7     Document Type: Article

References (29)

1. Zou J, Poe D, Bjelke B, Pyykkö I. Visualization of inner ear disorders with MRI in vivo: from animal models to human application. Acta Oto-Laryngol 2009;129:22-31.
2. Sosnovik D, Weissleder R. Emerging concepts in molecular MR Current Opinion in Biotechnology 2007, 18:4-10
3. Popper A, Fay R. The Cochlea, Springer Handbook of Auditory Research ed. by Peter Dallos, (1996)
4. Leonova EV, Raphael Y. Organization of cell junctions and cytoskeleton in the reticular lamina in normal and ototoxically damaged organ of Corti. Hearing research 1997;113:14-28. (Pubitemid 27473759)
5. Hibino H, Kurachi Y. Molecular and physiological bases of the K+ circulation in the mammalian inner ear. Physiology (Bethesda, MD) 2006;21:336-45. (Pubitemid 44511761)
6. McDonald M, Watkin K. Investigations into the Physicochemical Properties of Dextran Small Particulate Gadolinium Oxide Nanoparticles. Acad Radiol 2006;13:421-427
7. Jacobs RE, Cherry SR. Complementary emerging techniques: high resolution PET and MRI. Curr Opin Neurobiol 2001;11:621.
8. Frias JC, Ma Y, Williams KJ, Fayad ZA, Fisher EA. Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging. Nano Lett 2006;6:2220-2224. (Pubitemid 44663808)
9. Morawski AM, Winter PM, Crowder KC, Caruthers SD, Fuhrhop RW, Scott MJ, Robertson JD, Abendschein DR, Lanza GM, Wickline SA. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med 2004;51:480-486. (Pubitemid 38298660)
10. Sosnovik D, Nahrendorf M, Weissleder R. Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications Basic Res Cardiol. 2008 March ; 103(2): 122-130
11. Sosnovik D, Weissleder R: Magnetic resonance and fluorescence based molecular imaging technologies. Prog Drug Res 2005, 62:83-115. (Pubitemid 41569583)
12. Gløgård C, Stensrud G, Hovland R, Fossheim S, Klaveness J. Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity. International Journal of Pharmaceutics 233 (2002) 131-140 (Pubitemid 34230425)
13. Lanza GM, Abendschein DR, Yu X, Winter PM, Karukstis KK, Scott MJ, Fuhrhop RW, Scherrer DE, Wickline SA: Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology. Acad Radiol 2002, 9(Suppl 2):S330-S331. (Pubitemid 34857711)
14. Winter PM, Caruthers SD, Yu X, Song SK, Chen J, Miller B, Bulte JW, Robertson JD, Gaffney PJ, Wickline SA et al.: Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 2003, 50:411-416. (Pubitemid 36950862)
15. Frias JC, Williams KJ, Fisher EA, Fayad ZA: Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. J Am Chem Soc 2004, 126:16316-16317. (Pubitemid 40081918)
16. Lipinski MJ, Amirbekian V, Frias JC, Aguinaldo JG, Mani V, Briley-Saebo KC, Fuster V, Fallon JT, Fisher EA, Dayad A: MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn Reson Med 2006, 56:601-610. (Pubitemid 44338879)
17. Shen T, Weissleder R, Papisov M, Bogdanov A Jr, Brady TJ: Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 1993, 29:599-604. (Pubitemid 23138048)
18. Wunderbaldinger P, Josephson L, Weissleder R: Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. Acad Radiol 2002, 9(Suppl 2):S304-S306. (Pubitemid 34857701)
19. Counter SA, Bjelke B, Klason T, Chen Z, Borg E. Magnetic resonance imaging of the cochlea, spiral ganglia and eighth nerve of the guinea pig. Neuroreport 1999;10:473-9. (Pubitemid 29333267)
20. Counter SA, Zou J, Bjelke B Klason T. 3D MRI of the in vivo vestibulo-cochlea labyrinth during Gd-DTPA-BMA uptake. Neuroreport 2003;14:1707-12. (Pubitemid 37323758)
21. Zou J, Pyykko I, Counter SAet al. In vivo observation of dynamic perilymph formation using 4.7 T MRI with gadolinium as a tracer. Acta oto-laryngologica 2003;123:910-5.
22. Thomsen H. Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide Eur Radiol. 2006 December; 16(12): 2619-2621.
23. Zou J, Pyykko I, Bjelke B Dastidar P, Toppila E. Communication between the perilymphatic scalae and spiral ligament visualized by in vivo MRI. Audiology & neuro-otology 2005;10:145-52. (Pubitemid 40663392)
24. Naganawa S, Satake H, Iwano S, Fukatsu H, Sone M, Nakashima T. Imaging endolymphatic hydrops at 3 tesla using 3D-FLAIR with intratympanic Gd-DTPA administration. Magn Reson Med Sci 2008;7:85-91.
25. Moffat BA, Reddy GR, McConville P, Hall DE, Chenevert TL, Kopelman RR, Philbert M, Weissleder R, Rehemtulla A, Ross BD. A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI. Mol Imaging 2003;2:324-332.
26. Wunderbaldinger P, Josephson L, Weissleder R. Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. Acad Radiol 2002;9(Suppl 2):S304-306.
27. Qin J, Laurent, Jo YS, Roch A, Mikhaylova M, Bhujwalla ZM, Muller RN, and Muhammed M. A High-Performance Magnetic Resonance Imaging T2 Contrast Agent. Adv. Mater. 2007, 19, 1874-1878
28. Qin J, Asempah I, Laurent S, Fornara A, Muller R, Muhammed M. Injectable Superparamagnetic Ferrogels for Controlled Release of Hydrophobic DrugsAdv. Mater. 2009, 21, 1354-1357
29. Kakigi A, Nishimura M, Takeda Tet al. Effects of gadolinium injected into the middle ear on the stria vascularis. Acta oto-laryngologica 2008;128:841-5.